Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Low seroprevalence and low incidence of infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) in pediatric hematopoietic cell transplantation donors and recipients: Polish nationwide study

K. Czyzewski, J. Fraczkiewicz, M. Salamonowicz, A. Pieczonka, O. Zajac-Spychala, A. Zaucha-Prazmo, J. Gozdzik, J. Styczynski

. 2019 ; 66 () : . [pub] 20191111

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20008222

Toxoplasmosis is a potentially fatal complication after hematopoietic cell transplantation (HCT). Pre-transplant seropositivity of graft recipient to Toxoplasma gondii (Nicolle et Manceaux, 1908) is an important factor for disease reactivation after HCT. As toxoplasmosis epidemiology varies all over the world, we performed a Polish nationwide retrospective cohort study to determine the seroprevalence of toxoplasmosis in donors and pediatric allogeneic and autologous HCT recipients and the incidence of clinically evident toxoplasmosis in this patient group. Polish adult donors had higher anti-T. gondii seroprevalence than Polish pediatric donors (28% vs 8%; OR = 4.4; p = 0.02) and allo-HCT recipients (28% vs 17%; OR = 1.9; p = 0.01). Clinically apparent disease occurred in 1% of allo-HCT recipients: it was diagnosed by PCR as cerebral and/or ocular toxoplasmosis and successfully treated with antiprotozoal therapy. Regarding current practice, no prospective screening for infection of T. gondii in pediatric HCT centres is being performed, but, vast majority of HCT pediatric patients are receiving anti-T. gondii active prophylaxis. Since pre-HCT T. gondii serology was not assessed in all HCT; recipients, we propose this test should be a standard practice. Standardisation of management with infection of T. gondii in children after HCT is needed.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc20008222
003      
CZ-PrNML
005      
20200702090850.0
007      
ta
008      
200608e20191111xr f 000 0|eng||
009      
AR
024    7_
$a 10.14411/fp.2019.019 $2 doi
035    __
$a (PubMed)31823860
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Czyzewski, Krzysztof $u Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland
245    10
$a Low seroprevalence and low incidence of infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) in pediatric hematopoietic cell transplantation donors and recipients: Polish nationwide study / $c K. Czyzewski, J. Fraczkiewicz, M. Salamonowicz, A. Pieczonka, O. Zajac-Spychala, A. Zaucha-Prazmo, J. Gozdzik, J. Styczynski
504    __
$a Literatura
520    9_
$a Toxoplasmosis is a potentially fatal complication after hematopoietic cell transplantation (HCT). Pre-transplant seropositivity of graft recipient to Toxoplasma gondii (Nicolle et Manceaux, 1908) is an important factor for disease reactivation after HCT. As toxoplasmosis epidemiology varies all over the world, we performed a Polish nationwide retrospective cohort study to determine the seroprevalence of toxoplasmosis in donors and pediatric allogeneic and autologous HCT recipients and the incidence of clinically evident toxoplasmosis in this patient group. Polish adult donors had higher anti-T. gondii seroprevalence than Polish pediatric donors (28% vs 8%; OR = 4.4; p = 0.02) and allo-HCT recipients (28% vs 17%; OR = 1.9; p = 0.01). Clinically apparent disease occurred in 1% of allo-HCT recipients: it was diagnosed by PCR as cerebral and/or ocular toxoplasmosis and successfully treated with antiprotozoal therapy. Regarding current practice, no prospective screening for infection of T. gondii in pediatric HCT centres is being performed, but, vast majority of HCT pediatric patients are receiving anti-T. gondii active prophylaxis. Since pre-HCT T. gondii serology was not assessed in all HCT; recipients, we propose this test should be a standard practice. Standardisation of management with infection of T. gondii in children after HCT is needed.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    12
$a transplantace hematopoetických kmenových buněk $x statistika a číselné údaje $7 D018380
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a kojenec $7 D007223
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prevalence $7 D015995
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a séroepidemiologické studie $7 D016036
650    _2
$a dárci tkání $x statistika a číselné údaje $7 D014019
650    _2
$a Toxoplasma $x izolace a purifikace $7 D014122
650    _2
$a toxoplazmóza $x krev $x epidemiologie $7 D014123
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Polsko $x epidemiologie $7 D011044
655    _2
$a časopisecké články $7 D016428
700    1_
$a Fraczkiewicz, Jowita $u Department of Pediatric Transplantation, Oncology and Hematology, Medical University, Wroclaw, Poland
700    1_
$a Salamonowicz, Malgorzata $u Department of Pediatric Transplantation, Oncology and Hematology, Medical University, Wroclaw, Poland
700    1_
$a Pieczonka, Anna $u Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, Poznan, Poland
700    1_
$a Zajac-Spychala, Olga $u Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, Poznan, Poland
700    1_
$a Zaucha-Prazmo, Agnieszka $u Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Medical University, Lublin, Poland
700    1_
$a Gozdzik, Jolanta $u Stem Cell Transplant Center, University Children's Hospital, Department of Clinical Immunology and Transplantology, Jagiellonian University Collegium Medicum, Krakow, Poland
700    1_
$a Styczynski, Jan $u Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland
773    0_
$t Folia parasitologica $x 1803-6465 $g Roč. 66(20191111) $w MED00011006
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31823860 $y Pubmed
856    41
$u https://folia.paru.cas.cz/pdfs/fol/2019/01/19.pdf $y plný text volně přístupný
910    __
$a ABA008 $b online $c $y p $z 0
990    __
$a 20200608 $b ABA008
991    __
$a 20200702090847 $b ABA008
999    __
$a ok $b bmc $g 1540456 $s 1098297
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 66 $e 20191111 $i 1803-6465 $m Folia parasitologica $n Folia parasitol. $x MED00011006
LZP    __
$b NLK118 $a Pubmed-20200608

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...